Pre-marketing Trial to Assess Safety and Efficacy of 'Volumizing Filler Based on Hyaluronic Acid and Recombinant Collagen'
"Clinical and Instrumental Evaluation of the Safety and Bio-revitalizing Effect on the Face of the Medical Device 'Volumizing Filler Based on Hyaluronic Acid and Recombinant Collagen'"
Taumedika s.r.l.
40 participants
Feb 1, 2026
INTERVENTIONAL
Conditions
Summary
Study to validate the safety and efficacy of the Hyaluronic Acid +Collagen filler 40 patients will undergo through 3 visits one to asses the health and apply the filler one after 4 weeks to check the results one after 16 weeks for the final check and results validation Safety assessed with analysis of the Adverse Events
Eligibility
Inclusion Criteria4
- all sexes
- caucasic
- to 70 years
- non smoker
Exclusion Criteria10
- Pregnancy
- milking
- smoker
- alcohol or drugs abuse
- change of BMI during the study
- previous facial surgery, implants, permanent treatments
- sensitivity to the product
- dermatological difficult frame
- health weakness
- treated with anticoagulants, antihistaminics, corticosteroids, antidepressants and other drugs impacting on the results
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
Intradermal injection
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT06336044